Dai Shuiyan, Kwok Chun Shing
The Second People's Hospital of Foshan, Foshan, China.
Department of Cardiology, Leighton Hospital, Mid Cheshire Hospitals NHS Foundation Trust, Crewe, United Kingdom.
PLoS One. 2025 Jun 4;20(6):e0318424. doi: 10.1371/journal.pone.0318424. eCollection 2025.
Pulmonary rehabilitation (PR) is a significant component of chronic obstructive pulmonary disease (COPD) management, but whether it has any impact on patient sleep quality is unknown.
We conducted a systematic review of the literature to evaluate the impact of PR on sleep quality in patients with COPD. Searches of the MEDLINE, EMBASE and Cochrane Library databases were performed, and data were extracted from relevant studies. Meta-analysis with the random effects model was performed to determine if PR is associated with any difference in the Pittsburgh Sleep Quality Index (PSQI).
A total of 16 studies were included in this review with 1,478 patients, of which 1,169 took part in PR. The PR programmes were variable, some being 8-week programmes while others were 12-week, and some lasted for 6 months. The pooled results of 372 patients suggest that PR is associated with a significant improvement in the PSQI (mean difference 2.33 95% CI 0.46 to 4.20, I2 = 93%, 6 studies). Removal of one study, significantly reduced the statistical heterogeneity and the effect size (mean difference 0.91 95% CI 0.35-1.48, I2 = 0%, 5 studies). For other outcomes such as sleep onset latency, wake after sleep onset, total sleep time, sleep efficiency, and number of awakenings, there were no consistencies to suggest any benefit associated with PR.
PR appears to be associated with improvements in sleep quality in patients with COPD. More studies are needed to determine what the ideal PR programme is that best improves sleep quality and whether certain patients benefit more compared to others.
肺康复(PR)是慢性阻塞性肺疾病(COPD)管理的重要组成部分,但它对患者睡眠质量是否有影响尚不清楚。
我们对文献进行了系统评价,以评估PR对COPD患者睡眠质量的影响。检索了MEDLINE、EMBASE和Cochrane图书馆数据库,并从相关研究中提取数据。采用随机效应模型进行荟萃分析,以确定PR是否与匹兹堡睡眠质量指数(PSQI)的任何差异相关。
本评价共纳入16项研究,涉及1478例患者,其中1169例参与了PR。PR方案各不相同,一些是为期8周的方案,另一些是12周的,还有一些持续6个月。372例患者的汇总结果表明,PR与PSQI的显著改善相关(平均差异2.33,95%CI 0.46至4.20,I² = 93%,6项研究)。排除一项研究后,显著降低了统计异质性和效应量(平均差异0.91,95%CI 0.35 - 1.48,I² = 0%,5项研究)。对于其他结果,如入睡潜伏期、睡眠中觉醒、总睡眠时间、睡眠效率和觉醒次数,没有一致的结果表明PR有任何益处。
PR似乎与COPD患者睡眠质量的改善有关。需要更多的研究来确定能最佳改善睡眠质量的理想PR方案是什么,以及与其他患者相比,某些患者是否受益更多。